Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
134.80    3.20 (2.43%)
Bid:
134.40
Ask:
135.10
Spread: 0.70 (0.521%)
Market Cap: £340.89m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Acquisition

12 Dec 2018 07:00

RNS Number : 1815K
Marshalls PLC
12 December 2018
 

12 December 2018

LEI: 213800S21IFC367J5V62

 

 

 

Acquisition of Edenhall Holdings Limited

 

 

Marshalls plc ("Marshalls" or "the Group"), a leading hard landscaping manufacturer, announces today the acquisition of Edenhall Holdings Limited ("Edenhall"), a major UK independent concrete brick manufacturer and a leading supplier of concrete facing bricks, for an initial cash consideration of £11.8 million and deferred consideration of up to £5.4 million. The acquisition is on a cash free / debt free basis and net debt of £5.2 million has been deducted to derive the initial cash consideration.

 

Commenting on the transaction, Martyn Coffey, Chief Executive of Marshalls, said:

 

"Marshalls' strategy is to grow both organically and through carefully selected earnings enhancing bolt-on acquisitions with a particular focus on those parts of the market where higher levels of growth are anticipated, including New Build Housing, Road, Rail and Water Management. The acquisition of Edenhall represents a significant step towards achieving further growth in the New Build Housing market. Edenhall is a profitable business with a strong track record of quality, reliability and service, primarily targeting builders' merchants and regional and national housebuilders. The acquisition is in line with our stated strategy of expanding into adjacent building products related to New Build Housing."

 

Background

 

Marshalls manufactures and distributes hard landscaping products (concrete and natural stone paving), minerals including aggregates, ready mix mortar and street furniture. In the year ended 31 December 2017 the Group reported revenue of £430.2 million and profit before tax of £52.1 million. It has manufacturing sites in the UK and Belgium, and overseas offices in the US, Dubai and China. It employs around 2,300 people.

 

Edenhall was established in 1997 and generated revenue from continuing operations of £33.0 million and profit before tax of £2.8 million in the financial year ended 31 December 2017. It operates from 10 manufacturing sites across the UK employing around 250 people. It has a head office in Newport in South Wales. Edenhall manufactures and sells a range of solid and perforated concrete bricks, facings and walling products as well as a variety of cast stone products. Edenhall reported gross assets of £17.0 million at 31 December 2017.

 

The Transaction

 

Under the terms of the acquisition, Marshalls Mono Limited (a wholly owned subsidiary of Marshalls plc) has agreed to acquire 100% of the issued share capital of Edenhall Holdings Limited. The selling shareholders comprise the former directors of Edenhall Holdings Limited. The initial consideration for the shares is £11.8 million payable in cash, subject to any adjustment for specified changes in working capital. In addition, deferred consideration is payable up to a maximum of £5.4 million and dependent on business performance over a 3 year period. The acquisition will be funded from existing Group facilities, which are being strengthened by an additional Revolving Credit Facility of £25 million with RBS. This will support the Group's existing portfolio of committed revolving credit facilities in order to maintain the Group's existing level of facility headroom.

 

The acquisition of Edenhall is expected to be earnings enhancing in its first full year after completion and generate returns in excess of the Group's weighted average cost of capital.

 

Andrew Cotton, Managing Director of Edenhall Holdings Limited, will remain with the business and will join Marshalls' senior management team.

 

Andrew Cotton commented that the joining of two great companies will add real value to our customers and accelerate the growth of Edenhall.

 

The information contained within this Announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation. Upon the publication of this Announcement via a regulatory information service, this inside information is now considered to be in the public domain.

 

Conference Call

 

There will be a conference call for analysts and investors today at 8.00am with a telephone dial in facility of +44 333 300 0804, access code 926 147 58#. There will also be a playback facility available for analysts and investors who are unable to dial in +44 (0) 333 300 0819, access code 301 273 285#. A Marshalls' Presentation will be available for analysts and investors who are unable to dial in. The presentation can be viewed on Marshalls' website at www.marshalls.co.uk.

 

 

 

Enquiries:

 

Martyn Coffey

Chief Executive

Marshalls plc

01422 314777

Jack Clarke

Group Finance Director

Marshalls plc

01422 314777

Charlie Barker

MHP Communications

020 3128 8540

 

 

 

Forward-Looking Statements:

 

Any statements in this release, to the extent that they are forward-looking, are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the markets in which Marshalls operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. More information about the factors that may affect Marshalls' performance is contained in the Annual Report to shareholders for the year ended 31 December 2017.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQLFFEVFELLLIT
Date   Source Headline
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 202612:17 pmRNSHolding(s) in Company
22nd May 20264:01 pmRNSDirector/PDMR Shareholding
22nd May 20263:58 pmRNSDirector/PDMR Shareholding
15th May 202611:04 amRNSDirector/PDMR Shareholding
15th May 202611:03 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
13th May 20263:08 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Trading Update
15th Apr 202612:17 pmRNSDirector/PDMR Shareholding
15th Apr 202612:15 pmRNSDirector/PDMR Shareholding
17th Mar 20263:01 pmRNSDirector/PDMR Shareholding
17th Mar 20262:59 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSFinal Results
16th Mar 20267:00 amRNSFinal Results
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS-RNotice of Engage Investor Presentation
13th Feb 20263:21 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
19th Jan 20267:01 amRNSTrading Statement
19th Jan 20267:00 amRNSDirectorate change
9th Jan 202612:40 pmRNSDirector/PDMR Shareholding
9th Jan 202612:38 pmRNSDirector/PDMR Shareholding
6th Jan 20269:36 amRNSNotice of Trading Update
9th Dec 20253:21 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSBoard changes
12th Nov 20257:00 amRNSTrading Update
10th Nov 202510:30 amRNSDirector/PDMR Shareholding
10th Nov 202510:29 amRNSDirector/PDMR Shareholding
10th Nov 202510:27 amRNSDirector/PDMR Shareholding
30th Oct 20259:01 amRNSNotice of Trading Update
9th Oct 202512:45 pmRNSDirector/PDMR Shareholding
9th Oct 202512:44 pmRNSDirector/PDMR Shareholding
9th Oct 202512:42 pmRNSDirector/PDMR Shareholding
10th Sep 202512:06 pmRNSDirector/PDMR Shareholding
10th Sep 202512:05 pmRNSDirector/PDMR Shareholding
10th Sep 202512:04 pmRNSDirector/PDMR Shareholding
12th Aug 20259:28 amRNSDirector/PDMR Shareholding
11th Aug 20251:57 pmRNSDirector/PDMR Shareholding
11th Aug 20257:00 amRNSHalf year results
7th Aug 20257:00 amRNSDirectorate Change
28th Jul 202512:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.